Recent preclinical studies highlight the potential of micro‑dosed lithium to modulate Alzheimer’s disease pathology and support neuronal health. This episode examines the molecular mechanisms, current evidence in Alzheimer’s models, and emerging considerations for safe use and monitoring. You will gain insights to navigate this evolving topic and support informed discussions around lithium micro‑dosing in Alzheimer’s care.
HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls
GUEST
Dawn Gerber, PharmD, BCGP, FASCP, FAzPA, CPAFH
Professor of Pharmacy Practice
Midwestern University
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/
CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe current evidence on the use of microdose lithium in Alzheimer's disease.
2. Identify pharmacist considerations for monitoring, patient selection, and safety in the context of lithium micro-dosing for Alzheimer's.
Rachel Maynard and Dawn Gerber have no relevant financial relationships to disclose.
0.05 CEU/0.5 Hr
UAN: 0107-0000-25-375-H01-P
Initial release date: 12/22/2025
Expiration date: 12/22/2026
Additional CPE details can be found here.
